Liraglutide vs Semaglutide vs GLP-1 for Medical Weight Loss Both semaglutide and liraglutide, which bind to the GLP-1 receptor, are prescribed for medical weight reduction
Next-generation molecules Newer molecules entering the GLP-1 space, including GLP-3 peptides , mazdutide , survodutide , and orforglipron , each have unique pharmacokinetic profiles that will require their own timing optimization strategies
BMI, Body mass index
Parents of all subjects provided written informed consent
, 36 , 1302-1315, doi: Yang, L., Venneti, S., and Nagrath, D
Last weeks JAMA had two articles on GLP-1 drugs that point to their promise for treatment of diseases beyond the conditions for which they are already approved by the FDA: obesity, diabetes, cardiovascular risk, sleep apnea and metabolic liver disease